Expression of concern
Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1
Paper Information
Record ID:
23128
Author(s):
Publication Date:
April 03, 2019
Retraction Date:
April 14, 2020
(5.6 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Orthopedics
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Orthopedics
Institutions:
Country:
šØš³ ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1080/21691401.2020.1752023Citations (12)
12
Total Citations8
Post-Retraction(66.7%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
1
After 2+ years
1029
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Identification of RALA as a Therapeutic Target and Prognostic Predictor of Osteosarcoma
Gentao Fan, Yan Zhu, Hao Zhu et al. (9 authors)
BioMed Research International
Open Access
Published: Feb 2023
1 citation
1 citation
1029 days after retraction
Conquering oncogenic KRAS and its bypass mechanisms
Pingping Hou, Yingshuang Wang
Theranostics
Open Access
Published: Jan 2022
12 citations
12 citations
627 days after retraction
Circular RNA-Related CeRNA Network and Prognostic Signature for Patients with Osteosarcoma
Gu Man, Ao Duan, Wanshun Liu et al. (8 authors)
Cancer Management and Research
Open Access
Published: Oct 2021
7 citations
7 citations
535 days after retraction
Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide
Zhe Hong, Zhendong Xiang, Pan Zhang et al. (9 authors)
Clinical and Translational Medicine
Open Access
Published: Jul 2021
28 citations
28 citations
443 days after retraction
Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Leyla Soleymani, Ali Zarrabi, Farid Hashemi et al. (11 authors)
Current Cancer Drug Targets
Published: Jun 2021
28 citations
28 citations
414 days after retraction
Long nonācoding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression
Xiliang Guan, Yufen Xu, Ju-fen Zheng
Oncology Reports
Open Access
Published: Oct 2020
23 citations
23 citations
185 days after retraction
Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1
ChiaoāYun Lin, Angel Chao, RenāChin Wu et al. (12 authors)
Journal of Molecular Medicine
Published: Jul 2020
8 citations
8 citations
84 days after retraction
Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R
Suresh Bugide, Keshab R. Parajuli, Suresh Chava et al. (10 authors)
Oncogenesis
Open Access
Published: May 2020
26 citations
26 citations
21 days after retraction
Retraction
Unknown Authors
Journal of Cellular Physiology
Published: Jan 2020
6 citations
6 citations
98 days before retraction
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng, He Cai, Manni Wang et al. (8 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Dec 2019
919 citations
919 citations
119 days before retraction
Vascular protection of salicin on IL-1Ī²-induced endothelial inflammatory response and damages in retinal endothelial cells
Yu Song, Tian Xia, Xuehong Wang et al. (4 authors)
Artificial Cells Nanomedicine and Biotechnology
Open Access
Published: May 2019
26 citations
26 citations
330 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #24439
Oct 22, 2020Quick Stats
Total Citations:
12
Years Since Retraction:
5.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025